We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Appoints Ambry Genetics as First CSP for Agilent’s Target Enrichment System for Next-Gen Sequencing

News   Oct 27, 2009

 
Agilent Appoints Ambry Genetics as First CSP for Agilent’s Target Enrichment System for Next-Gen Sequencing
 
 
 

RELATED ARTICLES

Safety and Efficacy Results From CRISPR/Cas9 Human Clinical Trials Are Positive

News

CRISPR Therapeutics and Vertex Pharmaceuticals have announced their interim safety and efficacy results from the CTX001 CRISPR/Cas9 gene-editing human clinical trials - and they're promising.

READ MORE

A Milestone Is Reached For New Leukemia Drug

News

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

READ MORE

Dangers of Mother's High-fat Diet for Unborn Child

News

High-fat maternal diets can cause life-long changes in the brain of the unborn offspring and it is unlikely that such damage can simply be reversed by a subsequent change of diet.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE